AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre
ECONOMY & POLICY

AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.
This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.
“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.
The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.
Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.
Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.
In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Related Stories

Gold Stories

Next Story
Infrastructure Energy

Asian Energy Services Q1 FY27 PAT Rises 129 Per Cent

Asian Energy Services Limited reported a 129 per cent year-on-year rise in net profit to Rs 128 million for Q1 FY27, compared with the corresponding quarter last year.Revenue increased 135 per cent year-on-year to Rs 2.71 billion, supported by continued momentum across its services business, disciplined execution and contributions from domestic and international operations. EBITDA grew 81 per cent year-on-year during the quarter.As of June 30, 2026, the company’s standalone order book stood at Rs 17.54 billion, with around 60 per cent coming from oil and gas services and 40 per cent from min..

Next Story
Infrastructure Urban

BioBTX to Build First Commercial-Scale Circular Chemicals Plant

Dutch circular chemistry technology developer BioBTX is building what it says will be the world’s first commercial-scale plant to convert mixed plastic waste into high-quality aromatic chemicals using its proprietary Integrated Catalytic Cracking Process (ICCP) technology.The facility will be built at Chemical Park Delfzijl on the northern coast of the Netherlands and is expected to create 35 jobs. Covestro, which has been a shareholder and strategic partner of BioBTX since 2024, holds a mid-single-digit million-euro investment in the company.BioBTX’s ICCP technology uses catalytic pyrolys..

Next Story
Real Estate

Awfis Q1 FY27 PAT Jumps 140% as Revenue Rises 27%

Awfis Space Solutions reported a 140 per cent year-on-year rise in consolidated profit after tax (PAT) to Rs 240 million for Q1 FY27, compared with Rs 100 million in the corresponding quarter last year.Revenue from operations increased 27 per cent to Rs 4.25 billion from Rs 3.35 billion, while EBITDA rose 28 per cent to Rs 1.62 billion. EBITDA margin improved to 38.2 per cent from 37.8 per cent. Profit before tax increased 135 per cent to Rs 240 million.The company's co-working business recorded 27 per cent year-on-year growth, supported by demand from enterprises, Global Capability Centres (G..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement